Cepheid Overview
- Year Founded
-
1996
- Status
-
Acquired/Merged
- Employees
-
4,972
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$3.7M
- Investors
-
2
Cepheid General Information
Description
Developer of molecular diagnostic systems focused on improving patient outcomes by enabling access to molecular testing. The company's technology offers rapid on-demand genetic, sexual health, SARS-CoV-2, virology, oncology and critical infectious disease testing options, thereby detecting and analyzing nucleic acids, including DNA, in samples such as blood, urine, food and industrial water.
Contact Information
Website
www.cepheid.com(Operating Subsidiary)
Corporate Office
- 904 Caribbean Drive
- Sunnyvale, CA 94089
- United States
Corporate Office
- 904 Caribbean Drive
- Sunnyvale, CA 94089
- United States
Cepheid Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Grant | 22-Mar-2020 | $3.7M | Completed | Profitable | ||
| 7. Grant | 31-Dec-2017 | Completed | Profitable | |||
| 6. Merger/Acquisition | 04-Nov-2016 | Completed | Profitable | |||
| 5. Grant | 13-Nov-2014 | Completed | Generating Revenue | |||
| 4. IPO | 23-Jun-2000 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series C) | 06-Mar-2000 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 30-Nov-1998 | $8.2M | Completed | Generating Revenue | ||
| 1. Early Stage VC (Series B) | 01-Apr-1998 | $8.2M | $8.2M | Completed | Generating Revenue |
Cepheid Comparisons
Industry
Financing
Details
Cepheid Competitors (16)
One of Cepheid’s 16 competitors is Q-linea, a Formerly VC-backed company based in Uppsala, Sweden.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Q-linea | Formerly VC-backed | Uppsala, Sweden | ||||
| StageZero Life Sciences | Corporation | Richmond Hill, Canada | ||||
| Agena Bioscience | Formerly PE-Backed | San Diego, CA | ||||
| RareCyte | Venture Capital-Backed | Seattle, WA | ||||
| Myriad Genetics | Corporation | Salt Lake City, UT |
Cepheid Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Cepheid Patents
Cepheid Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026226936-A1 | Biochip and biochip compensation system | Pending | 25-Apr-2025 | ||
| WO-2026212966-A1 | Fluid transfer device | Pending | 31-Mar-2025 | ||
| WO-2026156080-A1 | Chip carrier device assembly | Pending | 17-Jan-2025 | ||
| WO-2026156069-A1 | Molded component with curved channel | Pending | 17-Jan-2025 | ||
| WO-2026148315-A1 | Fast respiratory infection amplification assay | Pending | 06-Jan-2025 | C12Q1/6844 |
Cepheid Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Cepheid Former Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Advanced Technology Ventures | Venture Capital | Minority | ||
| Allen Family Philanthropies | Limited Partner | Minority | ||
| Band of Angels | Angel Group | Minority | ||
| CampVentures | Venture Capital | Minority | ||
| Gates Foundation | Not-For-Profit Venture Capital | Minority |
Cepheid Investments & Acquisitions (6)
Cepheid’s most recent deal was a Merger/Acquisition with InSilixa. The deal was made on 01-Dec-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| InSilixa | 01-Dec-2021 | Merger/Acquisition | Diagnostic Equipment | ||
| OncoMark | 01-Mar-2021 | Merger/Acquisition | Diagnostic Equipment | ||
| Laboratory Supply (customer relationship ) | 01-Oct-2014 | Corporate Asset Purchase | Buildings and Property | ||
| Stretton Scientific | 03-Nov-2008 | Merger/Acquisition | Distributors/Wholesale | ||
| Sangtec Molecular Diagnostics | 14-Feb-2007 | Merger/Acquisition | Diagnostic Equipment |
Cepheid ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Cepheid Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Stretton Scientific | Stretton, United Kingdom | 2002 |
Cepheid FAQs
-
When was Cepheid founded?
Cepheid was founded in 1996.
-
Where is Cepheid headquartered?
Cepheid is headquartered in Sunnyvale, CA.
-
What is the size of Cepheid?
Cepheid has 4,972 total employees.
-
What industry is Cepheid in?
Cepheid’s primary industry is Diagnostic Equipment.
-
Is Cepheid a private or public company?
Cepheid is a Private company.
-
What is Cepheid’s current revenue?
The current revenue for Cepheid is .
-
How much funding has Cepheid raised over time?
Cepheid has raised $27.3M.
-
Who are Cepheid’s investors?
Advanced Technology Ventures, Allen Family Philanthropies, Band of Angels, CampVentures, and Gates Foundation are 5 of 13 investors who have invested in Cepheid.
-
Who are Cepheid’s competitors?
Q-linea, StageZero Life Sciences, Agena Bioscience, RareCyte, and Myriad Genetics are some of the 16 competitors of Cepheid.
-
When was Cepheid acquired?
Cepheid was acquired on 22-Mar-2020.
-
Who acquired Cepheid?
Cepheid was acquired by Danaher.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
